Clinical trial

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

NCT03598621

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-23

PhasePHASE1

Study timeline

Study start (actual)2018-07-23Date precision: day

Registry last updated2020-01-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Semaglutide, 0.5 mg/mLDRUG

Semaglutide, 1.0 mg/mLDRUG

Semaglutide, 1.34 mg/mLDRUG

Semaglutide, 2.0 mg/mLDRUG

DV3372, 0.5 mg/mLDEVICE

DV3372, 1.0 mg/mLDEVICE

PDS290DEVICE

NovoPen®4DEVICE

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03598621 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.